Widespread neonatal brain damage following calcium channel blockade

Developmental Neuroscience

Volumn 29, Issue 3, 2007, Pages 213-231

  Turner, C P ^a   Miller, R ^a   Smith, C ^a   Brown, L ^a   Blackstone, K ^a   Dunham, S R ^a   Strehlow, R ^a   Manfredi, M ^a   Slocum, P ^a   Iverson, K ^a   West, M ^a   Ringler, S L ^a   Berry, Z C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Brain development; Brain slice; Caspase 3; Glutamate; MK801; N Methyl D aspartate receptor; Primary neurons; Rat

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIZOCILPINE; NIMODIPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN DEVELOPMENT; BRAIN SLICE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; EMBRYO; FEMALE; NERVE CELL DIFFERENTIATION; NEWBORN; NEWBORN PERIOD; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CASPASE 3; CELLS, CULTURED; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; IN SITU NICK-END LABELING; MITOCHONDRIA; NEURONS; NIMODIPINE; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33847631170     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095221     Document Type: Article

References (88)

1. Alam A, Cohen LY, Aouad S, Sekaly RP (1999): Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 190: 1879-1890.
2. Arakawa Y, Nishijima C, Shimizu N, Urushidani T (2002): Survival-promoting activity of nimodipine and nifedipine in rat motoneurons: implications of an intrinsic calcium toxicity in motoneurons. J Neurochem 83: 150-156.
3. Berridge MJ, Lipp P, Bootman MD (2000): The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 11-21.
4. Brewer GJ, Price PJ (1996): Viable cultured neurons in ambient carbon dioxide and hibernation storage for a month. Neuroreport 7: 1509-1512.
5. Carafoli E (2002): Calcium signaling: a tale for all seasons. Proc Natl Acad Sci USA 99: 1115-1122.
6. Choi DW (1985): Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58: 293-297.
7. Choi DW, Maulucci-Gedde M, Kriegstein AR (1987): Glutamate neurotoxicity in cortical cell culture. J Neurosci 7: 357-368.
8. Collins F, Lile JD (1989): The role of dihydropyridine-sensitive oltage-gated calcium channels in potassium-mediated neuronal survival. Brain Res 502: 99-108.
9. Cragg BG (1975): The development of synapses in the visual system of the cat. J Comp Neurol 160: 147-166.
10. Dallwig R, Deitmer JW (2002): Cell-type specific calcium responses in acute rat hippocampal slices. J Neurosci Methods 116: 77-87.
11. Dobbing J, Sands J (1979): Comparative aspects of the brain growth spurt. Early Hum Dev 3: 79-83.
12. Duzenli S, Bakuridze K, Gepdiremen A (2005): The effects of ruthenium red, dantrolene and nimodipine, alone or in combination, in NMDA induced neurotoxicity of cerebellar granular cell culture of rats. Toxicol In Vitro 19: 589-594.
13. Farkas E, De Jong GI, Apro E, Keuker JI, Luiten PG (2001): Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain. Neurobiol Aging 22: 299-309.
14. Franklin JL, Johnson EM Jr (1994): Block of neuronal apoptosis by a sustained increase of steady-state free Ca2+ concentration. Philos Trans R Soc Lond B Biol Sci 345: 251-256.
15. Galli C, Meucci O, Scorziello A, Werge TM, Calissano P, Schettini G (1995): Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J Neurosci 15: 1172-1179.
16. Groenewegen HJ, Witter MP (2004): Thalamus; in Paxinos G (ed): The Rat Nervous System. San Diego, Elsevier, pp 407-453.
17. Grosse G, Djalali S, Deng DR, Holtje M, Hinz B, Schwartzkopff K, Cygon M, Rothe T, Stroh T, Hellweg R, Ahnert-Hilger G, Hortnag H (2005): Area-specific effects of brain-derived neurotrophic factor (BDNF) genetic ablation on various neuronal subtypes of the mouse brain. Brain Res Dev Brain Res 156: 111-126.
18. Guyer B, Hoyert DL, Martin JA, Ventura SJ, MacDorman F, Strobino DM (1999): Annual summary of vital statistics - 1998. Pediatrics 104: 1229-1246.
19. Gwag BJ, Canzoniero LM, Sensi SL, Demaro JA, Koh JY, Goldberg MP, Jacquin M, Choi DW (1999): Calcium ionophores can induce either apoptosis or necrosis in cultured cortical neurons. Neuroscience 90: 1339-1348.
20. Haberny KA, Paule MG, Scallet AC, Sistare FD, Lester DS, Hanig JP, Slikker W Jr (2002): Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicol Sci 68: 9-17.
21. Hack M, Taylor HG (2000): Perinatal brain injury in preterm infants and later neurobehavioral function. JAMA 284: 1973-1974.
22. Hagberg H, Gilland E, Diemer NH, Andine P (1994): Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biol Neonate 66: 205-213.
23. Han KS, Kang HJ, Kim EY, Yoon WJ, Sohn S, Kwon HJ, Gwag BJ (2001): 1,2-bis(2-Amino-phenoxy)ethane-N,N,N′,N′-tetra acetic acid induces caspase-mediated apoptosis and reactive oxygen species-mediated necrosis in cultured cortical neurons. J Neurochem 78: 230-239.
24. Hansen HH, Briem T, Dzietko M, Sifringer M, Voss A, Rzeski W, Zdzisinska B, Thor F, Heumann R, Stepulak A, Bittigau P, Ikonomidou C (2004): Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis 16: 440-453.
25. Harper JL, Camerini-Otero CS, Li AH, Kim SA, Jacobson KA, Daly JW (2003): Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem Pharmacol 65: 329-338.
26. Hwang JY, Kim YH, Ahn YH, Wie MB, Koh JY (1999): N-Methyl-D- aspartate receptor blockade induces neuronal apoptosis in cortical culture. Exp Neurol 159: 124-130.
27. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW (2000): Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287: 1056-1060.
28. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW (1999): Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-74.
29. Itoh T, Niwa H, Nagamatsu M, Mitsuma T, Miyakawa A, Pleasure D, Sobue G (1998): Nerve growth factor maintains regulation of intracellular calcium in neonatal sympathetic neurons but not in mature or aged neurons. Neuroscience 82: 641-651.
30. Jensen FE (2002): The role of glutamate receptor maturation in perinatal seizures and brain injury. Int J Dev Neurosci 20: 339-347.
31. Johnson EM Jr, Koike T, Franklin J (1992): A 'calcium set-point hypothesis' of neuronal dependence on neurotrophic factor. Exp Neurol 115: 163-166.
32. Joza N, Kroemer G, Penninger JM (2002): Genetic analysis of the mammalian cell death machinery. Trends Genet 18: 142-149.
33. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997): The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
34. Koh JY, Cotman CW (1992): Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists. Brain Res 587: 233-240.
35. Koike T, Martin DP, Johnson EM Jr (1989): Role of Ca2+ channels in the ability of membrane depolarization to prevent neuronal death induced by trophic-factor deprivation: evidence that levels of internal Ca2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc Natl Acad Sci USA 86: 6421-6425.
36. Lema Tome CM, Bauer C, Nottingham C, Smith C, Blackstone K, Brown L, Hlavaty C, Nelson C, Daker R, Sola R, Miller R, Bryan R, Turner CP (2006): MK801-induced caspase-3 in the postnatal brain: inverse relationship with calcium binding proteins. Neuroscience 141: 1351-1363.
37. Levitt P (2003): Structural and functional maturation of the developing primate brain. J Pediatr 143: S35-S45.
38. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997): Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489.
39. Lu SR, Liao YC, Fuh JL, Lirng JF, Wang SJ (2004): Nimodipine for treatment of primary thunderclap headache. Neurology 62: 1414-1416.
40. Luo CX, Zhu XJ, Zhang AX, Wang W, Yang XM, Liu SH, Han X, Sun J, Zhang SG, Lu Y, Zhu DY (2005): Blockade of L-type voltage-gated Ca channel inhibits ischemia-induced neurogenesis by down-regulating iNOS expression in adult mouse. J Neurochem 94: 1077-1086.
41. Maas JW Jr, Indacochea RA, Muglia LM, Tran TT, Vogt SK, West T, Benz A, Shute AA, Holtzman DM, Mennerick S, Olney JW, Muglia LJ (2005): Calcium-stimulated adenylyl cyclases modulate ethanol-induced neurodegeneration in the neonatal brain. J Neurosci 25: 2376-2385.
42. Mattson MP (1996): Calcium and free radicals: mediators of neurotrophic factor and excitatory transmitter-regulated developmental plasticity and cell death. Perspect Dev Neurobiol 3: 79-91.
43. McCarthy RT, TanPiengco PE (1992): Multiple types of high-threshold calcium channels in rabbit sensory neurons: high-affinity block of neuronal L-type by nimodipine. J Neurosci 12: 2225-2234.
44. Moran J, Itoh T, Reddy UR, Chen M, Alnemri ES, Pleasure D (1999): Caspase-3 expression by cerebellar granule neurons is regulated by calcium and cyclic AMP. J Neurochem 73: 568-577.
45. Mosmann T (1983): Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
46. Moulder KL, Fu T, Melbostad H, Cormier RJ, Isenberg KE, Zorumski CF, Mennerick S (2002): Ethanol-induced death of postnatal hippocampal neurons. Neurobiol Dis 10: 396-409.
47. Moyer JR Jr, Thompson LT, Black JP, Disterhoft JF (1992): Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner. J Neurophysiol 68: 2100-2109.
48. Nicholson DW (1999): Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6: 1028-1042.
49. Noer H, Kristensen BW, Noraberg J, Zimmer J, Gramsbergen JB (2002): 3-Nitropropionic acid neurotoxicity in hippocampal slice cultures: developmental and regional vulnerability and dependency on glucose. Exp Neurol 176: 237-246.
50. Nunez JL, Alt JJ, McCarthy MM (2003): A new model for prenatal brain damage. I. GABAA receptor activation induces cell death in developing rat hippocampus. Exp Neurol 181: 258-269.
51. Okoyama S, Kudo M (1997): Development of the tecto-thalamic projection neurons and the differential expressions of calcium-binding proteins in the rat. Int J Dev Neurosci 15: 813-822.
52. Olney JW, Ikonomidou C, Mosinger JL, Frierdich G (1989): MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 9: 1701-1704.
53. Olney JW, Tenkova T, Dikranian K, Muglia LJ, Jermakowicz WJ, D'Sa C, Roth KA (2002): Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol Dis 9: 205-219.
54. Oppenheim RW (1991): Cell death during development of the nervous system. Annu Rev Neurosci 14: 453-501.
55. Palomero-Gallagher N, Zilles K (2004): Isocortex; in Paxinos G (ed): The Rat Nervous System. San Diego, Elsevier, pp 729-757.
56. Park JS, Bateman MC, Goldberg MP (1996): Rapid alterations in dendrite morphology during sublethal hypoxia or glutamate receptor activation. Neurobiol Dis 3: 215-227.
57. Paxinos G, Watson A (1998): The Rat Brain in Stereotaxic Coordinates. San Diego, Academic Press.
58. Plane JM, Liu R, Wang TW, Silverstein FS, Parent JM (2004): Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse. Neurobiol Dis 16: 585-595.
59. Ricci A, Sabbatini M, Tomassoni D, Mignini F, Petrelli C, Amenta F (2002): Neuronal populations of rat cerebral cortex and hippocampus expressed a higher density of L-type Ca 2+ channel than corresponding cerebral vessels. Clin Exp Hypertens 24: 715-726.
60. Rice D, Barone S Jr (2000): Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(suppl 3): 511-533.
61. Rudolf R, Mongillo M, Rizzuto R, Pozzan T (2003): Looking forward to seeing calcium. Nat Rev Mol Cell Biol 4: 579-586.
62. Sabbatini M, Tomassoni D, Amenta F (2001): Hypertensive brain damage: comparative evaluation of protective effect of treatment with dihydropyridine derivatives in spontaneously hypertensive rats. Mech Ageing Dev 122: 2085-2105.
63. Shimizu N, Kishioka S, Maeda T, Fukazawa Y, Yamamoto C, Ozaki M, Yamamoto H (2004): Role of pharmacokinetic effects in the potentiation of morphine analgesia by L-type calcium channel blockers in mice. J Pharmacol Sci 94: 240-245.
64. Silverstein FS, Buchanan K, Hudson C, Johnston MV (1986): Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain. Stroke 17: 477-482.
65. Silverstein FS, McDonald JW 3rd, Bommarito M, Johnston MV (1990): Effects of hypoxia-ischemia and MK-801 treatment on the binding of a phencyclidine analogue in the developing rat brain. Stroke 21: 310-315.
66. Skattebol A, Triggle DJ (1987): Regional distribution of calcium channel ligand (1,4-dihydropyridine) binding sites and 45Ca2+ uptake processes in rat brain. Biochem Pharmacol 36: 4163-4166.
67. Skeen GA, Twyman RE, White HS (1993): The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol Pharmacol 44: 443-450.
68. Skeen GA, White HS, Twyman RE (1994): The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel. J Pharmacol Exp Ther 271: 30-38.
69. Takadera T, Matsuda I, Ohyashiki T (1999): Apoptotic cell death and caspase-3 activation induced by N-methyl-D-aspartate receptor antagonists and their prevention by insulin-like growth factor I. J Neurochem 73: 548-556.
70. Takadera T, Ohyashiki T (1998): Apoptotic cell death and CPP32-like activation induced by thapsigargin and their prevention by nerve growth factor in PC12 cells. Biochim Biophys Acta 1401: 63-71.
71. Takadera T, Suzuki R, Mohri T (1990): Protection by ethanol of cortical neurons from N-methyl-D-aspartate-induced neurotoxicity is associated with blocking calcium influx. Brain Res 537: 109-114.
72. Takashima S, Iida K, Deguchi K (1995): Periventricular leukomalacia, glial development and myelination. Early Hum Dev 43: 177-184.
73. Thayer SA, Usachev YM, Pottorf WJ (2002): Modulating Ca2+ clearance from neurons. Front Biosci 7: d1255-d1279.
74. Triggle DJ (1992): Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Cleve Clin J Med 59: 617-627.
75. Turner CP, Blackburn MR, Rivkees SA (2004): A1 adenosine receptors mediate hypoglycemia-induced neuronal injury. J Mol Endocrinol 32: 129-144.
76. Turner CP, Pulciani D, Rivkees SA (2002): Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol 178: 21-32.
77. Tymianski M, Bernstein GM, Abdel-Hamid KM, Sattler R, Velumian A, Carlen PL, Razavi H, Jones OT (1997): A novel use for a carbodiimide compound for the fixation of fluorescent and non-fluorescent calcium indicators in situ following physiological experiments. Cell Calcium 21: 175-183.
78. Uchida S, Yamada S, Nagai K, Deguchi Y, Kimura R (1997): Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists. Life Sci 61: 2083-2090.
79. Uematsu D, Greenberg JH, Araki N, Reivich M (1991): Mechanism underlying protective effect of MK-801 against NMDA-induced neuronal injury in vivo. J Cereb Blood Flow Metab 11: 779-785.
80. Vannucci SJ, Hagberg H (2004): Hypoxia-ischemia in the immature brain. J Exp Biol 207: 3149-3154.
81. Vogt BA, Vogt L, Farber NB (2004): Cingulate cortex and disease models; in Paxinos G (ed): The Rat Nervous System, ed 3. San Diego, Elsevier, pp 705-727.
82. Wang C, Fridley J, Johnson KM (2005): The role of NMDA receptor upregulation in phencyclidine-induced cortical apoptosis in organotypic culture. Biochem Pharmacol 69: 1373-1383.
83. Watanabe M, Inoue Y, Sakimura K, Mishina M (1992): Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3: 1138-1140.
84. Witter MP, Amaral DG (2004): Hippocampal formation; in Paxinos G (ed): The Rat Nervous System. San Diego, Elsevier, pp 635-704.
85. Yamada S, Uchida S, Ohkura T, Kimura R, Yamaguchi M, Suzuki M, Yamamoto M (1996): Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine. J Pharmacol Exp Ther 277: 721-727.
86. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997): Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132.
87. Yoon WJ, Won SJ, Ryu BR, Gwag BJ (2003): Blockade of ionotropic glutamate receptors produces neuronal apoptosis through the Bax-cytochrome C-caspase pathway: the causative role of Ca2+ deficiency. J Neurochem 85: 525-533.
88. Yu B, Wang C, Liu J, Johnson KM, Gallagher JP (2002): Adaptation to chronic PCP results in hyperfunctional NMDA and hypofunctional GABA(A) synaptic receptors. Neuroscience 113: 1-10.